COMMUNIQUÉS West-GlobeNewswire

Conatus Pharmaceuticals to Present at BioCentury NewsMakers Conference
29/08/2018
SAN DIEGO , Aug. 29, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]
Intercept to Present at Upcoming Investor Conferences
29/08/2018
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Aptose to Present at Upcoming Investor Conferences in September 2018
29/08/2018
SAN DIEGO and TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Calithera Biosciences to Participate in the Citi 13th Annual Biotech Conference and the Wells Fargo Healthcare Conference
29/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today announced [...]
BioCryst Pharmaceuticals to Present at the Baird Global Healthcare Conference
29/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the company will present at the Baird Global Healthcare Conference in New York on [...]
Arcturus Therapeutics Announces Appointment of Ernst & Young LLP as the Company’s Independent Auditor
29/08/2018
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“Arcturus” or the “Company”) (NASDAQ: ARCT), a leading RNA medicines company, today announced that at the Company’s Annual General Meeting of [...]
Bellicum Pharmaceuticals to Participate in Two Healthcare Investor Conferences in September
29/08/2018
HOUSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Axovant to Present at Upcoming Investor Conferences
29/08/2018
BASEL, Switzerland, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will participate in two upcoming investor conferences. Dr Cheruvu [...]
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September
29/08/2018
iTeos Therapeutics to Participate in Upcoming U.S. Conferences in September Gosselies, Belgium – August 29, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced [...]
Codexis to Present at Three Investment Conferences in September
29/08/2018
REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences: H.C. [...]
Cyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment Conference
29/08/2018
BERKELEY HEIGHTS, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
Akcea Therapeutics to Present at the Wells Fargo Healthcare Conference
29/08/2018
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc.(NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today announced that management will present a company overview at the Wells Fargo [...]
Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
29/08/2018
OXFORD, United Kingdom and CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that Mr Glyn Edwards, Chief Executive Officer, will present on the Company’s [...]
Kamada Provides Updated Full-Year 2018 Revenue Guidance
29/08/2018
As result of the recent labor strike part of 2018 shipments are likely to be delayed to early 2019 Subsequent update and full-year 2019 revenue guidance to be provided later this year REHOVOT, Israel, Aug. 29, 2018 ( [...]
Chimerix to Participate in September Investor Conferences
29/08/2018
DURHAM, N.C., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that company management will participate in [...]
Asterias Biotherapeutics’ CEO Michael Mulroy to Participate on Regenerative Medicine Therapies Panel at the B. Riley FBR Healthcare Conference
29/08/2018
FREMONT, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
CLINUVEL delivers second positive financial result
29/08/2018
European revenues re-invested in novel R&D MELBOURNE, Australia, Aug. 29, 2018 (GLOBE NEWSWIRE) -- EXECUTIVE SUMMARY – FINANCIAL YEAR 01 JULY TO 30 JUNE 2017/18 2016/17 Change Total Revenues $25.750m $16.984m 52% [...]
Poseida Therapeutics’ Clinical Update of BCMA-specific CAR-T Program Selected as a Late Breaking Presentation at the 4th Annual CAR-TCR Summit 2018
29/08/2018
Three presentations focus on Poseida’s clinical and preclinical CAR-T programs SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene [...]
Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany
29/08/2018
Press release August 29, 2018 Appeal of court ruling on Enzymatica's cold spray in Germany Enzymatica's distributor in Germany has appealed to the regional court of Frankfurt on their decision to put restrictions on the [...]

Pages